The association of hepatitis C virus infection with the prognosis of chronic hemodialysis patients: A retrospective study of 3,064 patients between 1999 and 2010

被引:3
作者
Tanaka, Junko [1 ]
Katayama, Keiko [1 ]
Matsuo, Junko [1 ]
Akita, Tomoyuki [1 ]
Asao, Takako [1 ]
Ohisa, Masayuki [1 ]
Tsuchiya, Shinichiro [2 ]
Yorioka, Noriaki [3 ]
机构
[1] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima 7348551, Japan
[2] Tsuchiya Gen Hosp, Hiroshima, Japan
[3] Gen Inc Assoc Hiroshima Kidney Org, Hiroshima, Japan
关键词
hemodialysis; HCV; diabetes; prognosis; BLOOD-DONORS; JAPAN; PREVALENCE; HIROSHIMA; CARRIERS; DISEASE;
D O I
10.1002/jmv.24160
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of hepatitis C virus (HCV) infection is high among patients receiving chronic hemodialysis. To clarify the risk ratio of HCV infection with respect to mortality and prognosis in chronic hemodialysis patients, a retrospective longitudinal cohort study was conducted in 2010 and involved 3,064 patients receiving chronic hemodialysis at nine dialysis facilities in Hiroshima, Japan, who were recruited from 1999 to 2003. Logistic regression and Cox hazards models were used to estimate the mortality risk among hemodialysis patients. Among the patients, 422 (14.0%) were positive for HCV RNA. HCV RNA positivity was associated with death in the logistic model (adjusted odds ratio=1.79; P<0.001). However, it was not a risk factor for the reduced of survival rate in the Cox proportional hazard model (adjusted risk ratio=1.07; P=0.4138). In summary, among hemodialysis patients, HCV RNA is correlated with the mortality rate; however, it is not significantly correlated with prognosis in terms of survival time. On the other hand, diabetes and age at dialysis onset are significantly correlated with survival. Diabetes control treatment should be preferentially selected for hemodialysis patients, and antiviral therapy for HCV should be introduced based on the clinical state of the patient. J. Med. Virol. 87:1558-1564, 2015. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:1558 / 1564
页数:7
相关论文
共 14 条
  • [1] Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients
    Espinosa, M
    Martin-Malo, A
    de Lara, MAA
    Ajama, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) : 1669 - 1674
  • [2] The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies
    Fabrizi, F.
    Takkouche, B.
    Lunghi, G.
    Dixit, V.
    Messa, P.
    Martin, P.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 697 - 703
  • [3] Fabrizi F, 2010, ACTA GASTRO-ENT BELG, V73, P465
  • [4] INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
    KIYOSAWA, K
    SODEYAMA, T
    TANAKA, E
    GIBO, Y
    YOSHIZAWA, K
    NAKANO, Y
    FURUTA, S
    AKAHANE, Y
    NISHIOKA, K
    PURCELL, RH
    ALTER, HJ
    [J]. HEPATOLOGY, 1990, 12 (04) : 671 - 675
  • [5] Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003
    Kumagai, J
    Komiya, Y
    Tanaka, J
    Katayama, K
    Tatsukawa, Y
    Yorioka, N
    Miyakawa, Y
    Yoshizawa, H
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (04) : 498 - 502
  • [6] Nakai S, 2014, THER APHER DIAL, V47, P1
  • [7] Seropositivity for Anti-HCV Core Antigen is Independently Associated With Increased All-Cause, Cardiovascular, and Liver Disease-Related Mortality in Hemodialysis Patients
    Ohsawa, Masaki
    Kato, Karen
    Tanno, Kozo
    Itai, Kazuyoshi
    Fujishima, Yosuke
    Okayama, Akira
    Turin, Tanvir Chowdhury
    Onoda, Toshiyuki
    Suzuki, Kazuyuki
    Nakamura, Motoyuki
    Kawamura, Kazuko
    Akiba, Takashi
    Sakata, Kiyomi
    Fujioka, Tomoaki
    [J]. JOURNAL OF EPIDEMIOLOGY, 2011, 21 (06) : 491 - 499
  • [8] OKAMOTO H, 1990, JPN J EXP MED, V60, P215
  • [9] Natural history of chronic hepatitis C
    Seeff, LB
    [J]. HEPATOLOGY, 2002, 36 (05) : S35 - S46
  • [10] Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000
    Tanaka, J
    Kumagai, J
    Katayama, K
    Komiya, Y
    Mizui, M
    Yamanaka, R
    Suzuki, K
    Miyakawa, Y
    Yoshizawa, H
    [J]. INTERVIROLOGY, 2004, 47 (01) : 32 - 40